Fig. 1From: Incidence and predictors of fragility fracture in postmenopausal rheumatoid arthritis patients receiving oral bisphosphonates: a longitudinal observational studyCumulative incidence curve with 95% confidence intervals for the endpoint defined as the development of any fragility fracturesBack to article page